European Urology

Papers
(The H4-Index of European Urology is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Re: Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate in Bladder Cancer1141
Manfred Wirth – A life devoted to urology in a time of change1092
Editorial Board608
The Platinum Hall of Fame551
More Than Words: Defining Adjuvant, Consolidative, and Salvage Treatment after Radical Prostatectomy535
Infigratinib Versus Placebo for Patients with High-risk Resected Urothelial Cancer Bearing an FGFR3 Genomic Alteration: Results from the PROOF302 Phase 3 Trial504
Honing Stratification and Treatment for High-risk Prostate Cancer468
Re: Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma384
Re: Carlotta Nedbal, Patrick Juliebø-Jones, Eamonn Rogers, et al. Improving Patient Information and Enhanced Consent in Urology: The Impact of Simulation and Multimedia Tools. A Systematic Literature 372
Editorial Board328
Prostate Cancer Active Surveillance Without Biopsy? Not Quite Yet, but Watch This Space313
Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret’s Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prosta249
P266 – From stones to strokes: How calcium kidney stones signal carotid atherosclerosis through oxidative stress239
P082 – Age disparity in couples seeking first medical help for infertility has changed over the last twenty years: A sociological study221
P203 – Systemic immune inflammation and stress urinary incontinence190
A0546 – The diagnostic potential of the penile cavernous density measurement by ultrasound178
P639 – Site-specific differences of eligibility for adjuvant immunotherapy among urothelial carcinoma patients treated with radical surgery: Results of a multicenter cohort study176
A0459 – Is there an oncological benefit of extended pelvic lymph node dissection at the time of radical prostatectomy in PSMA-PET node negative prostate cancer patients? Results from a multi-instituti169
A0519 – Efficacy and tolerability of androgen receptor targeted agents (ARTAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) in different treatment sequences164
V115 – Management of pelvic vessels injury during robotic pelvic urooncology procedures155
A0248 – Natural and assisted conceptions in young men treated for hematological cancer who stored their semen for fertility preservation153
A0872 – Real-world experience and long-term survival of high-risk non-muscle invasive bladder cancer treated with BCG: 5-year outcomes from a large UK tertiary referral centre144
A0228 – A randomized controlled trial comparison of stent-related symptoms between anti-reflux stents and standard double-J stents in school-age children133
P369 – Predictors of intraoperative conversion from robotic to open radical cystectomy and effects on patients survival128
P410 – Perioperative and oncological outcomes of incomplete thermal ablations with or without immediate retreatment for patients with small renal masses124
P505 – The role of prostate-specific antigen after cryotherapy for primary localized prostate cancer119
A0150 – Enrolment of racial and ethnic minority group patients in contemporary non-prostate cancer urological clinical trials: A systematic review113
GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)113
P190 – The impact of radiographic disappearance of metastases as a new surrogate marker for therapy in patients with metastatic hormone-sensitive prostate cancer113
P225 – Effect of preoperative urine culture timing on postoperative outcomes of retrograde intrarenal surgery: Preliminary results of the RIRSearch study111
A0759 – Vecto® prostate biopsy: 4-year outcomes of novel MRI-US fusion, transperineal prostate biopsies under local anaesthesia, utilising electromagnetic needle tracking110
A0484 – Endourology clinic: Artificial intelligence vs. natural intelligence104
A0607 – What is the optimal BCR-free survival cut-off predicting favourable long-term outcomes? A multicenter retrospective EMPaCT study102
A0622 – Single-port nerve-sparing radical prostatectomy – initial learning curve of a high-volume multi-port surgeon99
A0634 – Evaluation of Salvage High Intensity Focused Ultrasound (S-HIFU) and hemi-S-HIFU for radiorecurrent prostate cancer97
A0276 – OPUS program: Organized prostate cancer screening in Mexico97
P393 – Identification, validation and pathway enrichment analysis of differentially expressed genes and miRNAs as diagnostic biomarkers in clear cell renal cell carcinoma96
A0493 – Updated meta-analysis of VI-RADS score in image-guided assessment of muscle invasiveness in bladder cancer Pre-TURBT92
A0611 – Prediction of prostate cancer biochemical recurrence by a specific collagen-related proteo-transcriptomics signature92
A0321 – Definition of risk categories for urethral stricture recurrence after free graft bulbar urethroplasty using classification and regression tree analysis91
A0492 – Adopting stone volume instead of maximum stone diameter: Worth it or an academic fantasy? Results from a worldwide survey91
A0866 – A randomized, open-label, controlled clinical study to assess the digital health application INKA in the management of therapy refractory overactive bladder and mixed incontinence89
A0347 – The genotype-phenotype association in von Hippel-Lindau (VHL) disease with the codon 167 missense mutations: A large retrospective study/a population-based study89
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided 87
Ischemia Time Has Little Influence on Renal Function Following Partial Nephrectomy: Is It Time for Urology to Stop the Tick-Tock Dance?87
Do women choose urology residency as much as men? Female urology resident representation in Spain in the last decade85
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update85
Prostate-Specific Antigen Screening in Transgender Patients83
Reply to Felix Melchior, Andreas Pircher, and Isabel Heidegger’s Letter to the Editor re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinica82
Re: Johann S. de Bono, Meng He, Chen Shi, et al. Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential82
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled Trial79
Reply to Jonas Hugosson. Population-based Screening for Prostate Cancer: Is It Time? Eur Urol. 2025;87:340–34177
Re: Marcio Covas Moschovas, Shady Saikali, Marco Sandri, et al. Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robot77
A0486 – Comparison of 1-mm vs. 0.5-mm thick reconstructed images to evaluate residual stone fragments and dust particles: An evaluation using porcine kidneys76
P033 – Is the routine histological analysis of paediatric foreskin specimens following a circumcision justified?74
A0100 – Day care PCNL: Who Qualifies? Introducing the day-care PCNL checklist73
P526 – Single port versus multiport robotic nephroureterectomy with bladder cuff exicision: Comparative study for initial cases72
A0078 – IP8-FLUORESCE: A prospective paired-cohort study evaluating fluorescence confocal microscopy for rapid evaluation of surgical margins in radical prostatectomy72
A0796 – Cost-effectiveness analysis of treatments for BCG-unresponsive high-risk NMIBC72
A0677 – Bladder EpiCheck triggered photodynamic diagnosis biopsies detect high grade recurrences missed by white light cystoscopy71
P213 – The influence of STAT1 butyrylation in the prostate transition zone on benign prostatic hyperplasia via the NOTCH1/ATF3 pathway70
P219 – The quality of life of pregnant patients after active and delayed endourological treatment of urolithiasis70
P547 – Genomic insights into intraductal carcinoma of the prostate from the Genomic Umbrella Neoadjuvant Study (GUNS) in high-risk localized prostate cancer69
Re: W. Marston Linehan, Cathy Anne Pinto, Yanfang Liu, et al. Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease. Eur Urol 2025;88:56–6369
Acknowledgement to Reviewers69
Re: Duration of Androgen Deprivation Therapy with Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-course Versus Short-course Androgen Deprivation Therapy in the RADICALS-HD Random68
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy67
0.089969873428345